Sibutramine Detected in Weight Loss Supplement
The FDA is advising consumers to not buy or use Asset Bold, a product sold for weight loss.
An FDA analysis confirmed that Asset Bold contains sibutramine, a controlled substance that was removed from the market in 2010 due to safety concerns. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may pose a significant risk in patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Asset Bold is sold on various websites and in some retail stores.
For more information call (855) 543-3784 or visit FDA.gov.